| Crescent Capital BDC, Inc. (CCAP) Q1 2025 Earnings Conference Call Transcript |
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q1 2025 - Earnings Conference Call May 15, 2025 12:00 PM ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lombard - CFO Conference Call Participants Paul Johnson - KBW Robert Dodd - Raymond James Finian O'Shea - Wells Fargo Mickey Schleien - Ladenburg Thalmann Operator Good morning, and welcome to Crescent Capital BDC, Inc. First Quarter Ended March 31, 2025 Earnings Conference Call. Please note that Crescent Capital BDC, Inc. may be referred to as CCAP, Crescent BDC or the company throughout the call. |
seekingalpha.com |
2025-05-15 17:16:46 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Lag Estimates |
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.63 per share a year ago. |
zacks.com |
2025-05-14 22:45:22 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share |
LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.45 per share and net income of $0.11 per share, for the quarter ended March 31, 2025. Net asset value (NAV) per share was $19.62 at March 31, 2025 compared to $19.98 as of December 31, 2024. |
globenewswire.com |
2025-05-14 20:30:00 |
Czytaj oryginał (ang.) |
| My Income Portfolio: In The Garden Of Eden |
Total Return can be misleading if not supported by NAV growth, as it may include unsustainable distributions and Return of Capital. Behavioral finance shows markets are irrational, making it crucial to consider practical aspects beyond theoretical Total Return calculations. I believe that NAV performance can affect our discretion in the reinvestment choices for the distributions we receive from our savings much more than Total Return. |
seekingalpha.com |
2025-05-05 17:27:24 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2025 Financial Results |
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2025 on Wednesday, May 14, 2025 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 15, 2025 at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results. |
globenewswire.com |
2025-04-22 20:30:00 |
Czytaj oryginał (ang.) |
| I'm Buying 2 Income Machines With 5-12% Yields |
Spring is an ideal time for income investors to revisit portfolios, focusing on quality stocks like Crescent Capital BDC and Federal Realty Trust. Crescent Capital BDC offers a 12.4% yield, strong dividend coverage, and a diversified, conservatively managed portfolio, trading at a 24% discount to NAV. Federal Realty Investment Trust has a 57-year dividend growth streak, high-quality retail assets, and a 4.8% yield, trading well below historical valuation norms. |
seekingalpha.com |
2025-04-22 11:15:00 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC: Solid Dividend Coverage Supports Return Potential |
CCAP experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. CCAP's portfolio is 90% first-lien debt, with 85% in non-cyclical industries, ensuring priority in capital collection and defensive positioning. Diversification is key: top 10 investments hold only 15% of the portfolio, with an average position of 0.5% and low non-accruals. |
seekingalpha.com |
2025-03-26 11:38:51 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC: 11% Yield And 11% Discount Make It A Buy |
Crescent Capital BDC, Inc. offers a 10.6% dividend yield and trades at an 11% discount to book value, making it a compelling income investment. CCAP's portfolio is conservatively managed with 90% senior secured loans and strong private equity sponsorship, with low non-accruals. Despite lower base rates, CCAP maintains solid returns, supported by a healthy balance sheet and stable NAV/share, with management expecting increased deal activity. |
seekingalpha.com |
2025-03-25 17:52:32 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Crescent Capital BDC (CCAP) Stock? |
Investors need to pay close attention to Crescent Capital BDC (CCAP) stock based on the movements in the options market lately. |
zacks.com |
2025-03-24 13:40:18 |
Czytaj oryginał (ang.) |
| Bargain Alert: I'm Buying These 7-11% Yields For Recurring Income |
Market volatility underscores the need for income-producing assets; Crescent Capital BDC and Omega Healthcare Investors offer compelling value with strong fundamentals and attractive yields. Crescent Capital BDC carries a diversified portfolio, high-quality secured debt, robust liquidity, and an 11% dividend yield while trading at a 15% discount to NAV. Omega Healthcare Investors benefits from a stable triple-net lease model, improving operator fundamentals, and a 7.3% dividend yield, with potential for capital appreciation. |
seekingalpha.com |
2025-03-12 14:08:00 |
Czytaj oryginał (ang.) |
| My Income Portfolio: Financial Awareness |
The essence of financial awareness is to realize that money can work for us through our investments. Understanding the value of money is the first step toward financial education, which leads to the selection of the most appropriate tools for developing that awareness. In my case, the instruments I have adopted are largely high-income vehicles, with monthly and, in some cases, quarterly distribution. |
seekingalpha.com |
2025-03-10 15:50:52 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC: Q4 Earnings Showing Signs Of Weakness (Rating Downgrade) |
Crescent Capital BDC is downgraded due to a declining NII, and a less attractive discount to NAV. However, I don't see a reason for existing shareholders to sell. Despite recent weaknesses, CCAP maintains a strong dividend yield of 10.4%, supported by a healthy coverage rate and supplemental distributions for the next three quarters. The portfolio's high industry diversification and 90% first lien debt structure provide defensive measures, but higher interest rates challenge borrower performance. |
seekingalpha.com |
2025-03-06 10:33:53 |
Czytaj oryginał (ang.) |
| I'm Buying Magnificent Dividends Up To 9% Yield |
A contrarian mindset can help dividend investors find bargains, with Crescent Capital BDC and Cenovus Energy offering high yields after recent price drops. Crescent Capital BDC carries a diversified debt portfolio, strong dividend coverage, and a safe leverage profile, making it a compelling buy at a 9% discount to book value. Cenovus Energy's integrated operations and cost optimization efforts position it for long-term growth, with plans to return 100% of excess free cash flow to shareholders. |
seekingalpha.com |
2025-02-27 10:15:00 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. (CCAP) Q4 2024 Earnings Conference Call Transcript |
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q4 2024 Earnings Conference Call February 20, 2025 ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lombard - CFO Conference Call Participants Robert Dodd - Raymond James Mickey Schleien - Ladenburg Paul Johnson - KBW Operator Thank you for standing by. My name is Janine, and I will be your lead operator for today's call. |
seekingalpha.com |
2025-02-20 16:50:13 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC (CCAP) Q4 Earnings and Revenues Lag Estimates |
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.61 per share a year ago. |
zacks.com |
2025-02-19 21:11:07 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Reports Fourth Quarter 2024 Earnings Results; Declares a First Quarter Base Dividend of $0.42 Per Share and Series of Special Dividends |
LOS ANGELES, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $2.40 per share and net income of $1.99 per share for the year ended December 31, 2024. For the quarter ended December 31, 2024, net investment income and net income per share were $0.55 and $0.27, respectively. Reported net asset value (NAV) per share was $19.98 at December 31, 2024. The Company announced that its Board of Directors (the “Board”) declared a first quarter 2025 regular cash dividend of $0.42 per share to stockholders of record as of March 31, 2025, payable on April 15, 2025, and a series of special cash dividends related to undistributed taxable income in the aggregate amount of $0.15 per share, to be paid in three equal quarterly installments of $0.05 per share.1 |
globenewswire.com |
2025-02-19 18:30:00 |
Czytaj oryginał (ang.) |
| 3 Stocks From the Flourishing SBIC & Commercial Finance Industry |
A rise in financing demand across sectors on the back of economic resilience and relatively low rates will support companies like Main Street Capital, Barings BDC and Crescent Capital amid weakening asset quality. |
zacks.com |
2025-02-14 11:36:10 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC (CCAP) Expected to Beat Earnings Estimates: Should You Buy? |
Crescent Capital BDC (CCAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-12 13:06:29 |
Czytaj oryginał (ang.) |
| Yield Hunting Part 8: 7%+ In 1 Year From Crescent Capital BDC Baby Bonds |
Crescent Capital BDC focuses on originating and investing in the debt of private middle-market U.S. companies, aiming for income and capital appreciation. The 5% baby bond FCRX trades at $24.54 with a yield to maturity of 7.16%, offering a 2% higher yield compared to sector benchmarks. CCAP's adjusted credit score equivalent for financial strength is Baa2. It has strong profitability, asset quality, and leverage, though it relies on refinancing unsecured notes. |
seekingalpha.com |
2025-02-11 15:42:33 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2024 Financial Results |
LOS ANGELES, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2024 on Wednesday, February 19, 2025 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 20, 2025 at 12:00 p.m. Eastern Time to discuss its fourth quarter and year ended December 31, 2024 financial results. |
globenewswire.com |
2025-02-04 18:30:00 |
Czytaj oryginał (ang.) |
| Why Crescent Capital BDC (CCAP) is Poised to Beat Earnings Estimates Again |
Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-02-04 15:10:26 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC (CCAP) Upgraded to Buy: Here's Why |
Crescent Capital BDC (CCAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2025-02-04 15:01:42 |
Czytaj oryginał (ang.) |
| My 9.5% Income Portfolio-Like Mosaic Tiles |
Our investments, usually conceived and implemented gradually over time, are the pieces of a personal mosaic that form the whole of our assets. One solution for entering the financial markets can be Dollar-Cost Averaging (DCA), a form of investing a constant amount at regular intervals. However, initiating a plan to buy stocks according to the logic of DCA presupposes awareness of the fluctuations in financial markets and their psychological implications. |
seekingalpha.com |
2025-02-04 14:02:15 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC: High Dividend Yield Looks Solid |
Crescent Capital BDC, Inc. offers a solid dividend yield of around 8.6%, with strong dividend coverage that has led to specials being fairly regular. CCAP's portfolio is around 90% first-lien investments with over 97% floating rates, despite this, it appears to be less interest rate-sensitive to other BDCs due to its forms of borrowing. PIK income had increased dramatically in the latest quarter, though it was largely from one-time events; non-accruals stayed very low. |
seekingalpha.com |
2025-01-27 09:04:56 |
Czytaj oryginał (ang.) |
| Crescent Capital: Share Price Finally Catching Up To Fundamentals |
Crescent Capital BDC has shown strong price performance, solid financial growth, and high credit quality, making it a fundamentally sound buy despite a challenging economic backdrop. The BDC out-earned its dividend, grew its net asset value, and delivered impressive earnings, beating analysts' estimates with significant year-over-year growth. CCAP's strong balance sheet, with no debt maturing until 2026 and ample liquidity, positions it well for future growth and investment opportunities. |
seekingalpha.com |
2025-01-09 10:00:00 |
Czytaj oryginał (ang.) |
| My 9.5% Income Portfolio: Better With Less, But Better |
Risk is the probability of a negative event in the future. An abstract concept that is not measurable; otherwise it would not be risk. Ascertaining value is the first step in controlling risk, that is, in reducing the possibility of incurring losses that cannot be predicted in advance. My choice to invest in securities with positive NAV performance over time is a way to try to control risk. |
seekingalpha.com |
2024-12-30 16:05:36 |
Czytaj oryginał (ang.) |
| KBRA Assigns Rating to Crescent Capital BDC, Inc.'s $115 Million Senior Unsecured Notes Due 2028 and 2030 |
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a rating of BBB- to Crescent Capital BDC, Inc.'s (“CCAP” or “the company”) $115 million senior unsecured notes due in 2028 and 2030. The notes comprise a $35 million, 6.77% tranche and an $80 million, 6.90% tranche with maturities of February 18, 2028, and February 18, 2030, respectively. The rating Outlook is Positive. The notes are being issued in anticipation of 2026 unsecured note maturities. Key Credit Considerations The rating and Positive Outlook a. |
businesswire.com |
2024-12-27 12:24:00 |
Czytaj oryginał (ang.) |
| Crescent Capital's Outstanding Dividend Coverage Makes It A Buy |
CCAP is a defensive BDC with a 90% concentration on first-lien debt, ensuring high repayment priority during potential litigation processes. The portfolio focuses on non-cyclical businesses (85%), providing safety and predictability of cash flows, and the median EBITDA of its portfolio companies amounts to $27m. CCAP offers substantial distributions, including a $0.42 quarterly dividend per share and additional supplemental distributions, making it an attractive income holding. |
seekingalpha.com |
2024-12-19 15:29:54 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC : Material Agreement Form 8 K |
Item 1.01. Entry into a Material Definitive Agreement On December 3, 2024, Crescent Capital BDC, Inc. (the "Company") and certain subsidiaries of the Company entered into an Amended and Restated Senior Secured Revolving Credit Agreement (the "Revolving Credit Agreement") with Sumitomo Mitsui Banking Corporation as Administrative Agent ("Agent"), Collateral Agent, Lead Arranger, Sole Bookrunner and a lender, and certain other lenders named therein. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); The Revolving Credit Agreement amended and restated an existing Senior Secured Revolving Credit Agreement with Agent and, among other things, (i) decreased the size of the aggregate revolving commitment from up to $350,000,000.00 to up to $285,000,000.00, (ii) added an initial term commitment in an amount not to exceed $25,000,000.00 for an aggregate facility size of $310,000,000.00, (iii) increased the interest rate by 0.125% so that borrowings under the revolving commitment will bear interest at the applicable benchmark rate plus (A) 1.125% per annum for ABR Loans and 2.125% per annum for Term Benchmark Loans and RFR Loans if the Borrowing Base is less than 1.60 times the Combined Debt Amount and (B) 1.000% per annum for ABR Loans and 2.000% for Term Benchmark Loans and RFR Loans if the Borrowing Base is equal to or greater than 1.60 times the Combined Debt Amount, in each case, on outstanding amounts, or as otherwise determined by the Revolving Credit Agreement, (iii) extended the facility termination date from October 27, 2026 to December 3, 2029, unless otherwise terminated earlier under the Revolving Credit Agreement, and (iv) extended the facility revolving commitment period termination date from October 27, 2025, to December 1, 2028, unless otherwise terminated earlier under the Revolving Credit Agreement. Borrowings under the Revolving Credit Agreement remain subject to leverage restrictions contained in the Investment Company Act of 1940, as amended. The description above is only a summary of the material, amended provisions of the Revolving Credit Agreement and is qualified in its entirety by reference to a copy of the Revolving Credit Agreement, which is filed as Exhibit 10.1 to this current report on Form 8-K.Attachments Original document Permalink DisclaimerCrescent Capital BDC Inc. published this content on December 06, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on December 06, 2024 at 11:02:02.990. |
https://www.marketscreener.com |
2024-12-06 08:03:07 |
Czytaj oryginał (ang.) |
| I'm Buying Up To 9% Yield For Recurring Income |
Inflation makes Crescent Capital and Crown Castle compelling income-generating investments with yields of 9% and 6%, respectively. Crescent Capital offers a diversified portfolio with a strong 1st lien loan focus, high dividend coverage, and potential for capital appreciation. Crown Castle benefits from growing data demand and AI trends, providing essential infrastructure with a solid balance sheet and attractive valuation. |
seekingalpha.com |
2024-12-02 13:00:00 |
Czytaj oryginał (ang.) |
| My 9.5% Income Portfolio CEFs And Classic Cars |
Closed-end funds are special income vehicles, with many positive aspects and just as many weaknesses that take time to be properly understood and evaluated. I discovered their existence about ten years ago, and over time, I became convinced of their worth by developing a personal method of selection based mainly on NAV performance. This is an analytical, data-driven approach which I then extended to other types of securities in my portfolio, namely ETFs and BDCs. |
seekingalpha.com |
2024-11-18 02:43:51 |
Czytaj oryginał (ang.) |
| Crescent Capital: BDC Income And Promising Return With Small-Cap Exposures |
The recent rally in small-cap stocks indicates strong market confidence toward 2025, also making Crescent Capital BDC a compelling income investment. CCAP should benefit from a pro-small business tax policy and a favorable market environment, offering a 9.7% dividend yield for income seekers. Comparing CCAP with RVT shows similar total returns, with CCAP outperforming since inception, suggesting CCAP's strong performance in a rate-cut cycle. |
seekingalpha.com |
2024-11-15 09:43:34 |
Czytaj oryginał (ang.) |
| Crescent Capital: Q3 Earnings Reinforce Strong Total Return Potential |
Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is concentrated in health care and software, with 97% of debt investments on a floating rate basis. The rate of non-accruals still remains low, showing portfolio company resilience. This highlights CCAP's high-quality underwriting and financial health. |
seekingalpha.com |
2024-11-13 09:30:00 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. (CCAP) Q3 2024 Earnings Call Transcript |
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q3 2024 Earnings Conference Call November 12, 2024 12:00 PM ET Company Participants Dan McMahon - Head, Investor Relations Jason Breaux - Chief Executive Officer Henry Chung - President Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Paul Johnson - KBW Operator Good day, everyone. And welcome to the Third Quarter 2024 Crescent Capital BDC, Inc. Earnings Conference Call. |
seekingalpha.com |
2024-11-12 19:07:43 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC (CCAP) Beats Q3 Earnings and Revenue Estimates |
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.59 per share a year ago. |
zacks.com |
2024-11-12 10:25:14 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Reports Third Quarter 2024 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.42 Per Share, and a Third Quarter Supplemental Dividend of $0.07 Per Share |
LOS ANGELES, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.64 per share and net income of $0.41 per share for the quarter ended September 30, 2024. Reported net asset value per share was $20.20 as of September 30, 2024. |
globenewswire.com |
2024-11-12 08:15:00 |
Czytaj oryginał (ang.) |
| Crescent Capital: Buy This 9%-Yielding Cash Cow While It's Undervalued |
Crescent Capital BDC offers a compelling 9% regular yield and 11% total yield, supported by a diversified portfolio and strong earnings coverage. CCAP's portfolio quality is robust, with a low non-accrual rate and a strong balance sheet. CCAP trades at a material discount to book value and to its larger peers, making it an attractive high-yielding choice for income and value. |
seekingalpha.com |
2024-10-19 15:00:00 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2024 Financial Results |
LOS ANGELES, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the third quarter ended September 30, 2024 on Monday, November 11, 2024 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, November 12, 2024 at 12:00 p.m. Eastern Time to discuss its third quarter ended September 30, 2024 financial results. |
globenewswire.com |
2024-10-18 11:30:00 |
Czytaj oryginał (ang.) |
| My 9.5% Income Portfolio-Fifty Shades Of Blue |
My portfolio includes CEFs, ETFs, a few BDCs and an ETN, for whose selection I have developed over the years a criterion based mainly on NAV performance. In this article, however, I decided to focus on the price of each security in my portfolio, comparing it with the lows and highs touched throughout its history. An overview of the path each one has taken from launch to current market quotation with a personal assessment of the possible room for maneuver from those values. |
seekingalpha.com |
2024-10-17 15:15:50 |
Czytaj oryginał (ang.) |
| Why Crescent Capital BDC (CCAP) Could Beat Earnings Estimates Again |
Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2024-10-14 17:11:31 |
Czytaj oryginał (ang.) |
| 2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio |
Income investors should consider Crescent Capital BDC and Fidus Investment for their portfolios, as both trade below Net Asset Values and offer growth potential. CCAP, despite a short track record, shows strong investment activity, solid balance sheet, and consistent dividend payouts, making it a defensively positioned growth opportunity. FDUS has a longer track record, impressive dividend growth, and a solid balance sheet with a lower leverage ratio, offering stability and income reliability. |
seekingalpha.com |
2024-10-11 11:12:00 |
Czytaj oryginał (ang.) |
| Crescent Capital: 10% Yield, Low Pay-Out Ratio, 10% NAV Discount (Rating Upgrade) |
Crescent Capital BDC raised its base dividend by 2.4% in Q2 and continues to pay substantial supplemental dividends, enhancing passive income returns. With a low dividend payout ratio and a focus on First Liens, CCAP is a strong 'Buy' for passive income investors. Crescent Capital's net investment income covers its base dividend well, and its non-accrual ratio has improved, indicating high credit quality. |
seekingalpha.com |
2024-10-08 04:53:57 |
Czytaj oryginał (ang.) |
| I'm Buying Up To 9% Yield For Recurring Income |
An investor's cash flow should be measured alongside net worth as a measure of financial resiliency. Crescent Capital offers an 8.9% yield, focusing on first-lien loans in cash flow-generating, private equity-backed middle-market businesses, with a robust portfolio and strong financials. Federal Realty, a top-tier REIT, provides a 3.9% yield, high-quality mixed-use properties in affluent areas, and a 57-year streak of dividend increases. |
seekingalpha.com |
2024-09-24 12:10:00 |
Czytaj oryginał (ang.) |
| Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity |
Crescent Capital BDC has a well-diversified, defensive portfolio with 89.2% first-lien debt and decreasing non-accruals, indicating high portfolio quality. CCAP is sensitive to interest rate cuts due to its floating-rate debt investments, but lower interest expenses and increased market activity could somewhat offset this. Despite potential interest rate cuts, CCAP's dividends remain well-covered, with a strong net investment income per share providing robust dividend coverage. |
seekingalpha.com |
2024-09-18 05:22:50 |
Czytaj oryginał (ang.) |
| Crescent Capital BDC: A Reliable Dividend Payer |
Crescent Capital BDC boasts a robust portfolio with a low percentage of high-risk investments, ensuring solid NAV growth and consistent net investment income. CCAP offers an attractive forward dividend yield of 9.64%, rising to nearly 12% with special distributions, supported by a strong NII coverage ratio. Trading at a nearly 10% discount to NAV, Crescent Capital's valuation is justified by its consistent performance and potential for future NAV growth. |
seekingalpha.com |
2024-09-17 09:24:08 |
Czytaj oryginał (ang.) |